INTEC PHARMA LTD. Additional Paid in Capital
INTEC PHARMA LTD. had Additional Paid in Capital of $217.36 million as of 2020-12-31, per its 10-K filed 2021-03-16.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent › Additional Paid in Capital
us-gaap:AdditionalPaidInCapital · last filed 2021-03-16
- 2020-12-31: Additional Paid in Capital $217.36M.
- 2020-09-30: Additional Paid in Capital $217.33M.
- 2020-06-30: Additional Paid in Capital $211.69M.
- 2020-03-31: Additional Paid in Capital $206.79M.
| Period end | Additional Paid in Capital |
|---|---|
| 2020-12-31 | $217.36M 10-K · filed 2021-03-16 |
| 2020-09-30 | $217.33M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $211.69M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $206.79M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $200.23M 10-K · filed 2021-03-16 |
| 2019-09-30 | $199.63M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $196.87M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $195.84M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $194.64M 10-K · filed 2020-03-13 |
| 2017-12-31 | $156.36M 10-K · filed 2019-02-27 |